Conventional Trans-Resveratrol disperses poorly and can be slow to dissolve. Q-RESVERA is designed to address that delivery challenge.

PQNS Trans-Resveratrol vs standard Trans-Resveratrol — total resveratrol concentration over the first 12 hours after dose.

Trans-Resveratrol is a plant polyphenol studied across several areas of health. Explore an engineered delivery approach for these product concepts.
Oxidative-stress pathways and cellular protection are central areas of resveratrol research.
Research explores cellular stress resistance, mitochondrial function and aging-related pathways.
Research spans vascular biology and the regulation of glucose and lipid metabolism.
Research explores neuronal resilience, oxidative stress and cognitive aging.
Increasing the amount of Trans-Resveratrol alone may not resolve its delivery limitations. Q-RESVERA is designed to improve dispersion and availability for absorption, giving brands an ingredient proposition built around engineered delivery.
Trans-Resveratrol associated with phospholipids, designed for improved oral delivery.

Conventional Trans-Resveratrol disperses poorly and can be slow to dissolve. Q-RESVERA is designed to address that delivery challenge.
10.2× peak concentration (Cmax), 18.6× exposure over 0–24 h (AUC), and a modeled concentration of 112 vs 1.54 at 12 h — PQNS vs standard Trans-Resveratrol. Approximately 5× higher peak levels, prolonged circulation, and greater bioavailability.
QuanticSphere™ is a Phytosome Quantum Nano Sphere: Trans-Resveratrol associated with phospholipids, designed for improved oral delivery. Particle size 184.4 nm (DLS Z-average), surface charge +64.0 mV.
Antioxidant & cellular protection, healthy aging, cardiometabolic health, and cognitive wellness — research spans oxidative-stress pathways, cellular stress resistance and mitochondrial function, vascular biology and glucose/lipid metabolism, and neuronal resilience and cognitive aging.
Facility: NSF/ANSI 455-2 certified GMP, FSSC 22000, ISO 9001/14001/45001. Regulatory: 21 CFR Part 111, Halal Certified. Dissolution: approximately 95–100% release, batch-consistent. IP: QuanticSphere™ PQNS, patent pending 202521095813.
Share your formulation requirements and our team can walk you through the full Q-Resvera clinical dossier, supply format and technical specifications.
Talk to a SpecialistEnter your email to download the full PDF with clinical data, specifications and formulation details.